AI Analysis
Log in to generate an AI summary for this stock.
Log in to generate a MOAT report for this stock.
Log in to generate an earnings report for this stock.
Log in to generate an operating leverage report for this stock.
Log in to generate a management report for this stock.
Log in to generate a valuation report for this stock.
Teleflex Incorporated
Video analysis: TFX
All videosNo video analysis for this stock yet. Request one from our team.
News: TFX
TFX vs. PEN: Which Stock Is the Better Value Option?
Investors interested in Medical - Instruments stocks are likely familiar with Teleflex (TFX) and Penumbra (PEN). But which of these two stocks is more attractive to value investors?
Teleflex Appoints Veteran Medical Technology Executive Sean M. Salmon to Teleflex Board of Directors
WAYNE, Pa.--(BUSINESS WIRE)--Teleflex Incorporated (NYSE:TFX), a leading global provider of medical technologies, today announced the appointment of Sean M. Salmon to its Board of Directors, effective September 8, 2026. Mr. Salmon brings over three decades of global leadership experience in the medical device and pharmaceutical industries, culminating in more than 20 years at Medtronic plc (NYSE: MDT). He most recently served as Executive Vice President and President of its Cardiovascular Portf.
Public Employees Retirement System of Ohio Makes New Investment in Teleflex Incorporated $TFX
Public Employees Retirement System of Ohio purchased a new stake in Teleflex Incorporated (NYSE: TFX) in the undefined quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund purchased 12,584 shares of the medical technology company's stock, valued at approximately $1,595,000. Several other institutional investors have also recently
Teleflex Features Innovative Dynetic™-35 Balloon-Expandable Cobalt Chromium Stent System at CIRSE 2026
WAYNE, Pa.--(BUSINESS WIRE)--Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies, today announced it will showcase innovative technologies at CIRSE 2026 in Copenhagen, reinforcing its commitment to advancing innovation for healthcare providers. Among the featured technologies will be the Dynetic™-35 Balloon-Expandable Cobalt Chromium Stent System. This technology is supported by the previously presented BIONETIC-TRA study, an investigator-initiated study with a.
Bank of New York Mellon Corp Invests $33.36 Million in Teleflex Incorporated $TFX
Bank of New York Mellon Corp purchased a new position in Teleflex Incorporated (NYSE: TFX) during the undefined quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor purchased 263,156 shares of the medical technology company's stock, valued at approximately $33,358,000. Bank of
Should You Add Teleflex Stock to Your Portfolio Now?
TFX's Vascular growth, Interventional expansion and improved leverage support its outlook, while currency volatility remains a key risk.
TFX or PEN: Which Is the Better Value Stock Right Now?
Investors interested in Medical - Instruments stocks are likely familiar with Teleflex (TFX) and Penumbra (PEN). But which of these two companies is the best option for those looking for undervalued stocks?
Is TFX a Buy Now as Valuation Improves but Execution Risks Remain?
Valuation is improving for Teleflex, but slower Vascular Intervention integration and margin pressure keep execution risks in focus.
Similar companies
-
Merit Medical Systems, Inc.
MMSI
·
NASDAQ
Compare
-
Bausch + Lomb Corporation
BLCO
·
New York Stock Exchange
Compare
-
PTC Therapeutics, Inc.
PTCT
·
NASDAQ
Compare
-
Stevanato Group S.p.A.
STVN
·
New York Stock Exchange
Compare
-
Krystal Biotech, Inc.
KRYS
·
NASDAQ
Compare
-
Vaxcyte, Inc.
PCVX
·
NASDAQ
Compare